Bicuspid/Mitral, Stenosis and Tricuspid

Early experience with a novel transapical transcatheter aortic valve system in patients with severe aortic stenosis: a prospective, multicenter study

Frontiers in Cardiovascular Medicine

MARCH 20, 2025

At 30-day follow-up, all-cause mortality, the incidence of major adverse cardiovascular events, major vascular complications, and new permanent pacemaker implantation were 3.8%, 4.6%, 0.8%, and 0.8%, respectively. of patients showedmild paravalvular leakage, and all 125 (100%) patients were in New York Heart Association ClassII.

Aortic valve

Aortic valve Aortic Bicuspid/Mitral Stenosis

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

FEBRUARY 15, 2024

Food and Drug Administration ( FDA ) confirmed 13 to 1, with 0 abstention that the benefits of Abbott's TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people with tricuspid regurgitation (TR). On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.

Tricuspid

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035). Poverall=0.522; 1 year: 10% versus 2.3%

Aortic valve

Aortic valve Bicuspid/Mitral Aortic Tricuspid

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Conduction Disturbances and Outcome After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis

Circulation

OCTOBER 23, 2024

BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aortic valve replacement (SAVR) in patients with bicuspid aortic valve (BAV) aortic stenosis (AS) versus patients with tricuspid aortic valve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).

Aortic valve

Aortic valve Bicuspid/Mitral Aortic Tricuspid

AISAP’s CARDIO AI-powered Diagnostic Assessment Software Receives FDA Clearance

DAIC

AUGUST 27, 2024

Standalone performance for significant major valve disease pathology (aortic stenosis and regurgitation and mitral and tricuspid regurgitation) had a 93 percent sensitivity and 93 percent specificity.

Ultrasound

Ultrasound Tricuspid Bicuspid/Mitral Aortic

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left?sided valvular heart disease in Europe. Insights from the ESC?EORP Valvular Heart Disease II survey

European Journal of Heart Failure

FEBRUARY 19, 2024

Tricuspid regurgitation (TR): frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. ESC-EORP, European Society of Cardiology-EURObservational Research Programme; TV, tricuspid valve.

Tricuspid

Tricuspid Heart Disease Bicuspid/Mitral Heart Valves

Transcatheter versus surgical valve replacement in patients with bicuspid aortic valves: an updated meta-analysis

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. Single-arm studies, conference presentations, animal studies, and studies that involved patients with tricuspid aortic morphology were excluded. Medical databases were queried to pool comparative studies of interest.

Aortic valve

Aortic valve Bicuspid/Mitral Aortic TAVR

Progression of aortic stenosis after an acute myocardial infarction

Open Heart

JUNE 21, 2022

Background Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspid valves. It is unknown whether MI also induces pathological remodelling of the aortic valve and alters aortic stenosis (AS) progression.

Myocardial Infarction

Myocardial Infarction Aortic Aortic valve Stenosis

SAVR’s Value in the TAVR Era

CardiacWire

JANUARY 31, 2024

Much of these SAVR declines occurred in patients with tricuspid aortic valves (from 84.5% to 55% of total SAVRs), while SAVR ratios increased among patients with bicuspid aortic valves (from 15.5% That’s a positive trend given that <80yr SAVR patients with bicuspid aortic valves also had better-than-expected mortality rates.

TAVR

TAVR Aortic valve Bicuspid/Mitral Aortic

Atrial dilatation in Atrial fibrillation : A query with multiple twists!

Dr. S. Venkatesan MD

APRIL 28, 2024

However, underlying lesions such as hypertension, mitral valve disease, COPD, ASD, and TR greatly influence the degree of atrial enlargement. This is similar to MR begets MR. Atrial functional MR occurs when the lower part of the atria stretches the mitral annulus. No published proof as such.

Atrial Fibrillation

Atrial Fibrillation Bicuspid/Mitral Pulmonary Ablation

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

Open Heart

OCTOBER 19, 2022

Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic valve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. ±15.8 ±15.1 mm Hg, p value: 0.0079).

Aortic valve

Aortic valve Aortic Stenosis TAVR

Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

European Journal of Heart Failure

FEBRUARY 26, 2025

Proposed approach for clinical management and therapeutic optimization in patients with heart failure with reduced ejection fraction and low blood pressure. Low blood pressure with major or mild symptoms. **SBP SBP <80mmHg or symptomatic low BP or asymptomatic low BP.

Blood Pressure

Blood Pressure Heart Failure Aortic valve TAVR

Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit

DAIC

APRIL 5, 2024

Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis. The rapid adoption of transcatheter mitral and tricuspid therapies has also transformed the treatment landscape, expanding options for patients with structural heart disease.

Research

Research Heart Disease Best Practices Education

CRG Introduces New York Valves: The Structural Heart Summit

DAIC

APRIL 5, 2024

Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis. The rapid adoption of transcatheter mitral and tricuspid therapies has also transformed the treatment landscape, expanding options for patients with structural heart disease.

Heart Disease

Heart Disease Best Practices Education Tricuspid

Basics of Echocardiography

All About Cardiovascular System and Disorders

APRIL 4, 2024

Tracing in the lower part is tissue Doppler imaging from the medial mitral annulus. Opening and closing movements of the aortic and mitral valves are visible. Slight downward angulation of the transducer from this view gives the left ventricular cross section with mitral valve cross section within.

Bicuspid/Mitral

Bicuspid/Mitral Echocardiogram Tricuspid Aortic

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

APRIL 2, 2024

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected. the Roger L.

Tricuspid

Tricuspid Heart Valves Quality of Life Open-Heart Surgery

Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology

Heart BMJ

MARCH 22, 2024

Objective CT aortic valve calcium score (AVC score ) and density (AVC density ) thresholds have been recommended for aortic stenosis (AS) severity assessment in tricuspid aortic valve (TAV). We aimed to compare AVC score and AVC density in bicuspid aortic valve (BAV) versus TAV.

Bicuspid/Mitral

Bicuspid/Mitral Tricuspid Aortic Stenosis

Effect of aortic valve phenotype and sex on aorta dilation in patients with aortic stenosis

Open Heart

OCTOBER 17, 2024

Background Bicuspid aortic valve (BAV) is often associated with a concomitant aortopathy. This study aimed to compare the progression rate of aorta dimensions according to AV phenotype (BAV vs tricuspid AV (TAV)), fusion type and sex in patients with aortic stenosis (AS).

Aortic valve

Aortic valve Aortic Stenosis Bicuspid/Mitral

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Predictors of outcome in patients with moderate mixed aortic valve disease

Heart BMJ

APRIL 25, 2024

Objectives Grading the severity of moderate mixed aortic stenosis and regurgitation (MAVD) is challenging and the disease poorly understood. Methods Moderate MAVD was defined as coexisting moderate aortic stenosis (aortic valve area (AVA) 1.0–1.5 –1.5 cm 2 ) and moderate aortic regurgitation (vena contracta (VC) 0.3–0.6

Aortic valve

Aortic valve Aortic Outcomes Myocardial Infarction

Cardiology MCQ: Pulmonary hypertension by echo

All About Cardiovascular System and Disorders

DECEMBER 16, 2024

Bernoulli equation (P=4V 2 ) gives the gradient of tricuspid regurgitation flow, which corresponds to the pressure difference between right ventricle and right atrium in systole. If there is high right atrial pressure with elevated jugular venous pressure, 15 or 20 mm Hg may have to be added instead of 10 mm Hg.

Pulmonary

Pulmonary Hypertension Tricuspid Bicuspid/Mitral

Right ventricular dysfunction and impaired right ventricular–pulmonary arterial coupling in paradoxical low‐flow, low‐gradient aortic stenosis

European Journal of Heart Failure

DECEMBER 19, 2024

AF, atrial fibrillation; LAVI, left atrial volume index; RA, right atrial; RV, right ventricular; sPAP, systolic pulmonary artery pressure; SVI, stroke volume index; TR, tricuspid regurgitation. Aims Paradoxical low-flow, low-gradient aortic stenosis (pLFLG AS) may represent a diagnostic challenge, and its pathophysiology is complex.

Stenosis

Stenosis Aortic Pulmonary Aortic valve

Cardiovascular Update

Early experience with a novel transapical transcatheter aortic valve system in patients with severe aortic stenosis: a prospective, multicenter study

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Webinars

Conduction Disturbances and Outcome After Surgical Aortic Valve Replacement in Patients With Bicuspid and Tricuspid Aortic Stenosis

AISAP’s CARDIO AI-powered Diagnostic Assessment Software Receives FDA Clearance

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left?sided valvular heart disease in Europe. Insights from the ESC?EORP Valvular Heart Disease II survey

Transcatheter versus surgical valve replacement in patients with bicuspid aortic valves: an updated meta-analysis

Progression of aortic stenosis after an acute myocardial infarction

SAVR’s Value in the TAVR Era

Atrial dilatation in Atrial fibrillation : A query with multiple twists!

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit

CRG Introduces New York Valves: The Structural Heart Summit

Basics of Echocardiography

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology

Effect of aortic valve phenotype and sex on aorta dilation in patients with aortic stenosis

Published Research

Published Research

Predictors of outcome in patients with moderate mixed aortic valve disease

Cardiology MCQ: Pulmonary hypertension by echo

Right ventricular dysfunction and impaired right ventricular–pulmonary arterial coupling in paradoxical low‐flow, low‐gradient aortic stenosis

Stay Connected